Cisplatin/Paclitaxel/Pembrolizumab Regimen

Preferred Label : Cisplatin/Paclitaxel/Pembrolizumab Regimen;

NCIt synonyms : Cisplatin-Paclitaxel-Pembrolizumab; Cisplatin/Paclitaxel/Pembrolizumab; Cisplatin-Paclitaxel-Pembrolizumab Regimen;

NCIt related terms : Cisplatin, Paclitaxel, Pembrolizumab;

NCIt definition : A regimen consisting of cisplatin, paclitaxel, and pembrolizumab that can be used in the treatment of cervical, head and neck, vaginal and metastatic squamous non-small cell lung cancer (NSCLC).;

NCI Metathesaurus CUI : CL937603;

Codes from synonyms : 65367;

Details

Origin ID

C158033;

UMLS CUI

C4763995;

Semantic type(s)
- Therapeutic or Preventive Procedure [UMLS semantic type]
chemotherapy_regimen_has_component
- Cisplatin [NCIt concept]
- Paclitaxel [NCIt concept]
- Pembrolizumab [NCIt concept]
concept_is_in_subset
- HemOnc Regimen Terminology [NCIt concept]
- Multi-agent Therapeutic Regimens [NCIt concept]
- Pharmacotherapy Regimens [NCIt concept]
regimen_has_accepted_use_for_disease
- Lung Non-Small Cell Carcinoma [NCIt concept]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients